# BEIT

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beit

- Industry: Software
- Headquarters: Krakow, Poland
- Website: www.beit.tech
- Total disclosed funding: $1.4M
- Latest round: Seed (Oct 1, 2019)
- Investors on record: 6

## About

BEIT Inc. is a technology company focused on advanced molecular modeling solutions, using next-generation quantum-inspired algorithms to enhance computational chemistry for drug discovery applications.Founded in 2016 in Krakow, Poland, BEIT Inc. specializes in providing advanced molecular modeling solutions. The company has not undergone significant pivots or changes in operations. Wojtek Burkot founded the firm, which is currently led by CEO Paulina Mazurek. In October 2019, BEIT Inc. raised USD 1.4 mn in SEED funding, led by Kindred Capital, with participation from returning investors and new investors such as Bloomberg Beta and Data Collective. This funding round represents their total fundraising to date.BEIT Inc. specializes in advanced molecular modeling solutions, providing a suite of products that leverage next-generation quantum-inspired algorithms to enhance computational chemistry. Their core offerings include BDocker, BQChem, and WaferMol, designed to facilitate drug discovery and related applications through improvements in speed and precision. These products cater to pharmaceutical companies, research institutions, and biotechnology firms, optimizing molecular simulations and accelerating drug development processes, particularly in North America and Europe.BEIT Inc.'s revenue model is primarily based on subscription services and partnerships with clients in the pharmaceutical and biotechnology sectors. Their transactions include direct licensing agreements for flagship products like BDocker and BQChem, as well as collaborative agreements integrating their technologies into client operations. For the most recent year in 2023, BEIT Inc. reported revenue of USD 0 mn and an EBITDA of -USD 69,604.5.BEIT Inc. aims to utilize its recent funding to enhance their product offerings and expand into new markets. Upcoming products are being designed to further streamline drug discovery processes, although specific release dates have not been disclosed. The company is targeting expansion into additional European and North American markets to capitalize on the growing demand for computational chemistry solutions. The seed funding raised in October 2019 will support these initiatives, enabling BEIT Inc. to strengthen its position in the market.

## Funding rounds

- Seed, Oct 1, 2019, $1.4M — DCVC, Bloomberg Beta, Firebolt Ventures, Kindred Capital, S28 Capital, Manta Ray Ventures

## Investors

- DCVC (https://capitalatlas.ai/funds/dcvc) — Seed
- Bloomberg Beta (https://capitalatlas.ai/funds/bloomberg-beta) — Seed
- Firebolt Ventures (https://capitalatlas.ai/funds/firebolt-ventures) — Seed
- Kindred Capital (https://capitalatlas.ai/funds/kindred-capital) — Seed
- S28 Capital (https://capitalatlas.ai/funds/s28-capital) — Seed
- Manta Ray Ventures (https://capitalatlas.ai/funds/manta-ray-ventures) — Seed